SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-11-080945
Filing Date
2011-03-29
Accepted
2011-03-29 13:16:02
Documents
10
Effectiveness Date
2011-03-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 46868
2 GRAPHIC g168544not001a.jpg GRAPHIC 5735
3 GRAPHIC g168544not001b.jpg GRAPHIC 1152
4 GRAPHIC g168544not002a.jpg GRAPHIC 1156
5 GRAPHIC g168544not002b.jpg GRAPHIC 2054
6 GRAPHIC g168544not002c.jpg GRAPHIC 2199
7 GRAPHIC g168544not002d.jpg GRAPHIC 2077
8 GRAPHIC g168544not003.jpg GRAPHIC 1155
9 GRAPHIC g168544not004a1.jpg GRAPHIC 2656
10 GRAPHIC g168544not004c.jpg GRAPHIC 1806
  Complete submission text file 0001193125-11-080945.txt   76738
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 11718136
SIC: 2834 Pharmaceutical Preparations